Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Provenge – Treatment for Advanced Prostate Cancer

Drug (Brand / Generic)

Provenge / sipuleucel-T

Company / Licensee

Dendreon Corporation

Therapy Class

Autologous cellular immunotherapy

Current Indication

Advanced prostate cancer

Market Sector

Oncology

Development Status

Approved by the FDA
Expand
Close
Close
Close

Go Top